Intra-Cellular Therapies
ITCI
#1748
Rank
NZ$16.22 B
Marketcap
$153.01
Share price
0.86%
Change (1 day)
68.37%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Market cap: NZ$16.22 Billion

As of November 2024 Intra-Cellular Therapies has a market cap of NZ$16.22 Billion. This makes Intra-Cellular Therapies the world's 1748th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$16.22 B48.84%
2023NZ$10.89 B38.07%
2022NZ$7.89 B26.46%
2021NZ$6.24 B76.03%
2020NZ$3.54 B25.4%
2019NZ$2.82 B203.36%
2018NZ$0.93 B-16.23%
2017NZ$1.11 B18.05%
2016NZ$0.94 B-72.21%
2015NZ$3.39 B410.41%
2014NZ$0.66 B23.21%
2013NZ$0.53 B

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Intra-Cellular Therapies was reported to be:

NZ$16.22 Billion
by Yahoo Finance info icon info icon
NZ$16.22 Billion
by CompaniesMarketCap info icon info icon
NZ$16.22 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.12 B-99.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$44.6 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.77 B-82.92%๐Ÿ‡บ๐Ÿ‡ธ USA